FAQs About Flu and COVID Vaccines

After a positive COVID-19 test, patients should monitor their symptoms, limit close contact with others, and follow current respiratory illness precautions. Rest, hydration, and appropriate symptom management may be sufficient for uncomplicated cases. However, patients with risk factors for severe illness should contact a healthcare professional promptly because certain treatments must begin within a limited period after symptoms start. Difficulty breathing, persistent chest pain, or new confusion requires emergency medical attention.

Yes. COVID-19 rebound refers to symptoms returning or a new positive test after an initial recovery. It can occur in people who received antiviral treatment and in those who did not. Rebound symptoms are often mild and temporary, but patients may become contagious again. Anyone experiencing renewed symptoms should follow respiratory illness precautions and contact a healthcare professional if symptoms are worsening, persistent, or associated with an increased risk of complications.

Some COVID-19 antiviral medications have clinically important interactions with prescription medicines, over-the-counter products, and supplements. Certain treatments also require dosage adjustments or additional precautions for patients with kidney or liver conditions. Pregnancy and other individual circumstances may affect treatment selection. Patients should provide a complete medication list and medical history before treatment begins. A healthcare professional must assess contraindications, potential interactions, and appropriate alternatives rather than assuming every antiviral medication is suitable for everyone.

For eligible patients at increased risk of severe illness, COVID-19 antiviral treatment should begin as soon as possible. Depending on the treatment selected, initiation is generally required within five to seven days after symptoms first appear. A healthcare professional considers symptom severity, medical history, kidney and liver function, and other relevant factors before determining suitability. Patients at higher risk should not delay seeking medical advice while waiting for symptoms to become severe.

Yes. A negative rapid antigen test does not always exclude COVID-19, particularly when testing occurs early in the infection. For patients with symptoms, the FDA recommends repeating a negative antigen test after 48 hours, for at least two tests in total. Those without symptoms generally need three tests, each 48 hours apart, after an initial negative result. A molecular test, such as PCR, may be considered when greater diagnostic sensitivity is needed.

Long COVID is a chronic condition associated with SARS-CoV-2 infection that can affect one or more body systems for at least three months. Symptoms may include fatigue, difficulty concentrating, shortness of breath, sleep disturbances, or worsening symptoms after physical or mental exertion. Some patients experience fluctuating symptoms that interfere with everyday activities. Patients do not need to wait three months to seek care for persistent or concerning symptoms. Medical evaluation can help assess possible causes and identify appropriate management options.

Households should reduce close contact with the infected person whenever practical, improve indoor ventilation, practice regular hand hygiene, and consider well-fitting masks when sharing indoor spaces. Extra precautions are important when household members are older, immunocompromised, or otherwise vulnerable to severe illness. Frequently touched surfaces should be cleaned regularly. Caregivers should also monitor for worsening symptoms and seek medical advice promptly when a person develops breathing difficulties or other concerning changes.

Emergency warning signs include severe difficulty breathing, persistent chest pain or pressure, new confusion, inability to wake or remain awake, or pale, gray, or bluish discoloration of the skin, lips, or nail beds. These findings may indicate serious illness and require immediate assessment. Patients experiencing these symptoms should call 911 rather than waiting for a routine appointment. Other severe or rapidly worsening symptoms may also require urgent medical attention.

Seasonal influenza vaccination, precautions, and treatment

Influenza can sometimes lead to complications, including viral or bacterial pneumonia, dehydration, or worsening of existing medical conditions. A fever or cough that improves and then returns or becomes more severe may indicate a complication requiring assessment. Patients should seek prompt medical attention for worsening respiratory symptoms, significant weakness, or persistent fever. Severe breathing difficulty, chest pain, confusion, or other emergency warning signs require immediate medical care.

Influenza antiviral treatment provides the greatest benefit when started as early as possible, ideally within 48 hours of symptom onset. Treatment may still be recommended after that period for hospitalized patients, those with severe or progressive illness, and individuals at increased risk of complications. Medication selection depends on factors such as age, pregnancy, kidney function, and medical history. Certain inhaled antivirals are not recommended for people with underlying airway disease, including asthma or COPD.

No. Rapid influenza antigen tests may produce false-negative results, especially when influenza activity is high, or the test has limited sensitivity. A healthcare professional may still suspect influenza based on symptoms, exposure history, and examination findings. More sensitive molecular testing may be appropriate in selected circumstances. Patients at increased risk of complications may require prompt antiviral treatment even when an initial rapid test is negative, without waiting for additional confirmation.

Influenza vaccination is recommended during pregnancy because pregnant patients are at increased risk of serious influenza complications. Inactivated or recombinant flu vaccines can be administered during any trimester, while the live nasal spray vaccine should not be used during pregnancy. Maternal vaccination may also help protect infants during their first months of life through antibodies transferred during pregnancy. This protection is particularly important because infants younger than six months are not eligible for influenza vaccination.

A previous severe allergic reaction to an influenza vaccine or certain vaccine components may contraindicate a particular product and requires careful review. A history of Guillain-Barré syndrome within six weeks after an earlier flu vaccine is a precaution, while moderate or severe acute illness may justify delaying vaccination. Egg allergy alone does not prevent influenza vaccination under CDC guidance. Patients should disclose relevant allergies, prior vaccine reactions, and medical conditions so an appropriate vaccine can be selected.

September and October are generally recommended months for influenza vaccination for most eligible individuals, although vaccination can remain beneficial later while flu viruses circulate. Some children aged six months through eight years need two doses at least four weeks apart, depending on their previous vaccination history. Children aged nine years and older generally need one seasonal dose. A healthcare professional can review a child’s vaccination records to determine the appropriate schedule.

Additional safety questions about flu and COVID-19

Yes. A person can become infected with SARS-CoV-2 and an influenza virus simultaneously, a situation known as coinfection. Because symptoms overlap, identifying one virus does not automatically exclude infection with the other. Depending on the circumstances, a healthcare professional may recommend a combined molecular test that detects both viruses. Coinfection can increase the complexity of clinical management, particularly for patients with underlying medical conditions or severe respiratory symptoms.

Under general CDC community guidance, people with respiratory virus symptoms can usually resume normal activities once their symptoms have been improving overall for at least 24 hours and they have been fever-free without fever-reducing medication during that period. Additional precautions, including improved ventilation, masking, distancing, or testing, are recommended for the following five days. Individuals with weakened immune systems may remain contagious longer. Healthcare settings and certain workplaces may have additional requirements.

At Dr. Shima Hadidchi, MD Family Practice in Apple Valley, CA, our team provides personalized guidance to help patients navigate flu and COVID-19 concerns. We consider individual symptoms, medical history, underlying health conditions, and potential risk factors when discussing appropriate testing, treatment options, preventive measures, and medication safety. Whether you are experiencing respiratory symptoms, recovering from an infection, or concerned about possible complications, Dr. Shima Hadidchi emphasizes informed medical decisions and timely evaluation to support your health and well-being.

For more information, contact us or request an appointment online. We are conveniently located at 12740 Hesperia Rd, Suite A, Victorville, CA 92395. We serve patients from Victorville CA, Apple Valley CA, Spring Valley Lake CA, Hesperia CA, Baldy Mesa CA, Adelanto CA, and surrounding areas.

CDC. Interim Clinical Considerations for the Use of Seasonal Influenza Vaccines in the United States.
https://www.cdc.gov/flu/hcp/vax-summary/acip-recommendations.html
CDC. Clinical Guidance for Seasonal Influenza Vaccine Safety.
https://www.cdc.gov/flu/hcp/vax-summary/vaccine-safety.html
CDC. COVID-19 Treatment Clinical Care for Outpatients.
https://www.cdc.gov/covid/hcp/clinical-care/outpatient-treatment.html
CDC. Influenza Antiviral Medications: Summary for Clinicians.
https://www.cdc.gov/flu/hcp/antivirals/summary-clinicians.html
CDC. Self-Testing At Home or Anywhere.
https://www.cdc.gov/covid/testing/self-testing.html
CDC. Clinical Overview of Long COVID.
https://www.cdc.gov/covid/hcp/clinical-overview/
CDC. Preventing Spread of Respiratory Viruses When You’re Sick.
https://www.cdc.gov/respiratory-viruses/prevention/precautions-when-sick.html
CDC. Clinical Guidance for Outpatients With Acute Respiratory Illness at Higher Risk of Severe COVID-19 and/or Influenza.
https://www.cdc.gov/flu/hcp/clinical-guidance/testing-guidance-for-outpatient.html
CDC. Flu Vaccine Safety and Pregnancy.
https://www.cdc.gov/flu/vaccine-safety/vaccine-pregnant.html